Watch for New DOAC Guidance in Your Anticoagulation Policies

February 2019

You'll see more focus on maximizing safe use of direct oral anticoagulants (DOACs)...apixaban (Eliquis), etc.

The Joint Commission is expanding the anticoagulation National Patient Safety Goal (NPSG) starting July 1, 2019. The biggest change will be the addition of the DOACs.

Verify your policy addresses DOAC dosing, monitoring, interactions, etc...similar to what you have for warfarin and injectable anticoagulants.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Anticoagulants Watch for New DOAC Guidance in Your Anticoagulation Policies
Gastroenterology Refocus on Limiting PPIs or H2-Blockers for Stress Ulcer Prophylaxis
Infectious Diseases Reduce Empiric Broad-Spectrum Antibiotics for Pyelonephritis
Antibiotics Add Aortic Aneurysm to the List of Quinolone Concerns
Anticoagulants Avoid Overlapping Direct Oral Anticoagulants With Warfarin in Most Cases
Smoking Cessation Use a Cardiac Admission to Promote Smoking Cessation
Travel Medicine Don't Add the New Travelers' Diarrhea Med Rifamycin (Aemcolo) to Formulary
New Drugs Know How Tolsura Stacks Up to Other Itraconazole Capsules
Vitamins & Minerals Watch for Dosing Confusion With New Vitamin and Supplement Labeling

Watch for New DOAC Guidance in Your Anticoagulation Policies

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents